氟马西尼市场:用量，各用途，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

预计增加氟马西尼治疗昏迷的研发将推动全球氟马西尼市场的增长。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球氟马西尼市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球氟马西尼市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球氟马西尼市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球氟马西尼市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称的说明

第2章 市场概要

• 报告内容
  • 市场定义和范围
• 摘要整理
  • 市场明细:剂量
  • 市场明细:各应用领域
  • 市场明细，各流通管道
  • 市场明细，各地区
• 连贯机遇地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 法规方案
• PEST分析
• 最近的产品上市/核准
• 流行病学
• M&A(合併·收购)

第4章 氟马西尼的全球市场:冠状病毒(COVID-19)疫情的影响

• 供应链的影响
• 研究开发的影响
• 政府的配合措施

第5章 氟马西尼的全球市场:各剂量，2017年～2030年

• 5毫升
• 10毫升

第6章 氟马西尼的全球市场:各用途，2017年～2030年

• 镇静剂
• 消除困倦
• 其他(肝性脑病变，肝硬化)

第7章 氟马西尼的全球市场:各流通管道，2017年～2030年

• 医院内药局
• 零售药局
• 线上药局

第8章 氟马西尼的全球市场:各地区，2017年～2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地区
• 欧洲
• 德国
• 英国
• 法国
• 义大利
• 西班牙
• 俄罗斯
• 其他的欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 中东地区
• GCC
• 以色列
• 其他的中东地区
• 非洲
• 南非
• 中非
• 北非

第9章 竞争情形

• 企业简介
  • Hoffmann La Roche
• 药物组合
  • Akorn-Strides, LLC
• 医药品组合
  • Sandoz Canada Incorporated
• 医药品组合
  • Fresenius Kabi USA, LLC
• 医药品组合
  • Mylan Pharmaceuticals
• 医药品组合
  • Genentech, Inc.
• 药物组合
  • General Injectables & Vaccines Inc
• 药物组合
  • Sina Health Inc.
• 药物组合
  • West Ward Pharmaceutical
• 药物组合
  • HF Acquisition Co. LLC, DBA HealthFirst
• 药物组合
  • Hikma Farmaceutica
• 药物组合
  • Pfizer Laboratories Div Pfizer Inc.
• 药物组合
  • Physicians Total Care, Inc.
• 药物组合
  • Bedford Pharmaceuticals
• 药物组合

第10章 章节

• 参考文献
• 调查手法

Flumazenil is a benzodiazepine inhibitor Flumazenil are used as reversal drug for postsurgical sedation from benzodiazepine anesthetics. Flumazenil injection is recommended for a complete or partial reversal of the sedative effects of benzodiazepines in conscious sedation and general anesthesia in adult and pediatric populations.

Flumazenil is also designated for the management and treatment of benzodiazepine overdose in adults. It is used in reversing coma due to benzodiazepine overdose. Flumazenil is more effective in reversing coma in benzodiazepine intoxication than patients with multiple drug overdoses.

Market Dynamics

Increasing research and development for the treatment of coma using flumazenil is expected to propel growth of the global flumazenil market. For instance, according to research data published on May 9, 2021, in Journal of Medical Case Reports, researchers have reported that flumazenil has showed positive result in complete neurocognitive recovery of patient with a Glasgow Coma Score of 15. 0.25 mg of flumazenil was intravenously administered to the patient who was unresponsive with Glass Coma Score of 3. After the patient was directed with flumazenil, the patient completely recovered by neurocognitive.

Increasing cases of people facing drowsiness problem is expected to drive growth of the global flumazenil market, over the forecast period. For instance, according to data published by European Transport Workers' Federation, in 2019 a survey done in city of London, reported that among 1353 bus drivers 37% of the drivers had to fight with drowsiness in order to stay awake. Flumazenil is used for the treatment of patients suffering from drowsiness. Flumazenil injections given through vein are more effective to treat people facing drowsiness.

Key features of the study:

• This report provides an in-depth analysis of the global flumazenil market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global flumazenil market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Hoffmann La Roche, Akorn-Strides, LLC, Sandoz Canada Incorporated, Fresenius Kabi USA, LLC, Mylan Pharmaceuticals, Genentech, Inc., General Injectables & Vaccines Inc, Sina Health Inc, West Ward Pharmaceutical, HF Acquisition Co. LLC, DBA HealthFirst, Hikma Farmaceutica, Pfizer Laboratories Div Pfizer Inc., Physicians Total Care, Inc., and Bedford Pharmaceuticals
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global flumazenil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flumazenil market.

Detailed Segmentation:

• Global Flumazenil Market, By Dose:
  • 5 ml
  • 10 ml
• Global Flumazenil Market, By Application:
  • Anti - Sedation
  • Reversing Drowsiness
  • Others (Hepatic Encephalopathy, Cirrhosis)
• Global Flumazenil Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Flumazenil Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Hoffmann La Roche *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Akorn-Strides, LLC
  • Sandoz Canada Incorporated
  • Fresenius Kabi USA, LLC
  • Mylan Pharmaceuticals
  • Genentech, Inc.
  • General Injectables & Vaccines Inc
  • Sina Health Inc
  • West Ward Pharmaceutical
  • HF Acquisition Co. LLC, DBA HealthFirst
  • Hikma Farmaceutica
  • Pfizer Laboratories Div Pfizer Inc.
  • Physicians Total Care, Inc.
  • Bedford Pharmaceuticals

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Dose
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Scenario
• PEST Analysis
• Recent Product Launch/Approval
• Epidemiology
• Mergers and Acquisitions

4. Global Flumazenil Market - Impact of Coronavirus (Covid-19) Pandemic

• Impact on Supply Chain
• Impact on Research and Development
• Government Initiatives

5. Global Flumazenil Market, By Dose, 2017-2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• 5 ml
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• 10 ml
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Flumazenil Market, By Application, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Anti - Sedation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Reversing Drowsiness
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Others (Hepatic Encephalopathy, Cirrhosis)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Flumazenil Market, By Distribution Channel, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Flumazenil Market, By Region, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• U.S.
• Canada
• Latin America
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• South Africa
• Central Africa
• North Africa

9. Competitive Landscape

• Company Profiles
  • Hoffmann La Roche
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Akorn-Strides, LLC
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Sandoz Canada Incorporated
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Fresenius Kabi USA, LLC
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Mylan Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Genentech, Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • General Injectables & Vaccines Inc
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Sina Health Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • West Ward Pharmaceutical
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • HF Acquisition Co. LLC, DBA HealthFirst
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Hikma Farmaceutica
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Pfizer Laboratories Div Pfizer Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Physicians Total Care, Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Bedford Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us and Sales Contact